Zao Ren An Shen capsule for insomnia: a double-blind, randomized, placebo-controlled trial

失眠症 安慰剂 医学 双盲 随机对照试验 胶囊 内科学 麻醉 精神科 替代医学 生物 病理 植物
作者
Yoann Birling,Xiaoshu Zhu,Nicole Avard,Caterina Tannous,Paul Patrick Fahey,Jerome J. Sarris,Alan Bensoussan
出处
期刊:Sleep [Oxford University Press]
卷期号:45 (2) 被引量:17
标识
DOI:10.1093/sleep/zsab266
摘要

STUDY OBJECTIVES: The aim of this study was to test the efficacy and safety of Zao Ren An Shen (ZRAS) capsule, a Chinese herbal medicine product, for the treatment of insomnia. METHODS: We conducted a double-blind randomized placebo-controlled trial. After a one-week placebo run-in, a total of 85 people with insomnia were randomly allocated to receive ZRAS or placebo for 4 weeks. The primary outcomes were insomnia severity assessed with the Insomnia Severity Index (ISI) and the number of participants with adverse events (AEs). Secondary outcomes included objective and subjective sleep parameters, psychological status, fatigue level, quality of life, acceptability, and tolerability. RESULTS: A nonsignificant (p > .05) difference of 0.7 points in ISI in favor of ZRAS capsule was found at the end of the treatment. The number of participants with AEs was not significantly different (p > .05) between the two groups. Except for subjective sleep onset latency, which had a nonsignificant (p > .05) medium effect (Cohen's d = 0.5), the effects in secondary efficacy outcomes were all small (Cohen's d < .4) and nonsignificant (p > .05). The acceptability and tolerability were high in the active group. CONCLUSIONS: ZRAS capsule is safe, acceptable, and tolerable, yet not more effective than placebo in the treatment of insomnia. As previous evidence showed that Chinese herbal medicine was effective for insomnia, these results may be explained by the dose of the product, which was lower than the dose generally used in the clinic.Registration: This clinical trial was registered in Australia New Zealand Clinical Trial Registry (registration number ACTRN12619000140156) under the name "Impact of Zao Ren An Shen (ZRAS) capsule on chronic insomnia patients' insomnia severity: A randomized-controlled trial" (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=376730&isReview=true).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
mzt完成签到,获得积分10
1秒前
2秒前
2秒前
2秒前
FashionBoy的应助被corleeang采纳,获得10
3秒前
3秒前
3秒前
xs完成签到 ,获得积分10
3秒前
4秒前
情怀的应助被科研通管家采纳,获得10
4秒前
4秒前
搜集达人的应助被科研通管家采纳,获得10
4秒前
领导范儿的应助被天外来物采纳,获得10
4秒前
科研通AI2S的应助被科研通管家采纳,获得10
4秒前
充电宝的应助被科研通管家采纳,获得10
4秒前
1097发布了新的文献求助10
4秒前
aajhajkahna的应助被科研通管家采纳,获得10
4秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
深情安青的应助被科研通管家采纳,获得10
5秒前
5秒前
Owen的应助被科研通管家采纳,获得10
5秒前
心香驳回了MM的应助
5秒前
小马甲的应助被科研通管家采纳,获得10
5秒前
急急急发布了新的文献求助10
5秒前
molihuakai的应助被科研通管家采纳,获得10
5秒前
英俊的铭的应助被科研通管家采纳,获得10
5秒前
5秒前
n11发布了新的文献求助10
5秒前
Owen的应助被科研通管家采纳,获得10
5秒前
vnewgnl的应助被科研通管家采纳,获得20
6秒前
6秒前
星1993发布了新的文献求助10
6秒前
6秒前
春申君发布了新的文献求助10
6秒前
紧张的谷槐完成签到,获得积分10
6秒前
上官若男的应助被科研通管家采纳,获得10
6秒前
Hello的应助被科研通管家采纳,获得10
6秒前
小蘑菇的应助被科研通管家采纳,获得10
6秒前
orixero的应助被科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124